Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Tick-borne encephalitis vaccines: past and present.

Olaf Zent¹, Michael Bröker

¹Chiron Vaccines, Clinical Research and Medical Affairs, Chiron Behring GmbH & Co KG, Emil-von-Behring Str. 76, 35041 Marburg, Germany. olaf_zent@chiron.com

Expert Review of Vaccines

|October 14, 2005

Summary

Tick-borne encephalitis (TBE) vaccines have evolved with improved formulations and safety profiles. Recent data show longer immunity persistence, leading to extended booster intervals and increased vaccine use across all age groups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Letter to Editor: Rattanaumpawan et al. Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same author

Comment on: Pettersson et al. Qdenga-induced dengue caused by minor DENV-2 subvariant(s) in the vaccine, with two amino acid substitutions in the E protein.

Journal of travel medicine·2026

Same author

Inclusion of the Right Ventricular Muscle Bundle During Interventricular Septal Measurement Improves Diagnostic Accuracy for Hypertrophic Cardiomyopathy.

Echocardiography (Mount Kisco, N.Y.)·2025

Same author

Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccine.

Expert review of vaccines·2025

Same author

Ticks and tick-borne diseases from Mallorca Island, Spain.

Parasitology·2024

Same author

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.

The Lancet. Global health·2024

Area of Science:

Virology
Vaccinology
Epidemiology

Background:

Tick-borne encephalitis (TBE) is a significant viral zoonosis endemic in Europe and Asia.
TBE vaccines are crucial for preventing disease in endemic regions.
Existing TBE vaccines have undergone several modifications based on production advancements and postmarketing surveillance.

Observation:

Vaccine production shifted from mouse brain to primary cell cultures.
Formulations were updated with improved stabilizers and preservatives, and pediatric versions were introduced.
Rapid vaccination schedules and extended booster intervals are now recommended based on new data.

Findings:

Current TBE vaccines are safe, effective, and interchangeable.
Postmarketing surveillance confirms the favorable safety and efficacy profiles.

Related Experiment Videos

Serologic studies indicate a longer duration of protective immunity than previously assumed.

Implications:

Extended booster intervals for TBE vaccination are being adopted in Europe, with harmonization anticipated.
No major formulation changes or new vaccine targets are expected in the near future.
Increasing TBE vaccine utilization across all age demographics, including children, is projected due to epidemiological trends.